A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biosimilars industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market Segment by Product Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biosimilars consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biosimilars market by identifying its various subsegments.
3.Focuses on the key global Biosimilars manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biosimilars submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biosimilars Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilars Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilars Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Erythropoietin
2.1.4 Insulin
2.1.5 Vaccines
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Tumor
2.2.2 Diabetes
2.2.3 Cardiovascular
2.2.4 Hemophilia
2.2.5 Other
2.3 Global Biosimilars Market Comparison by Regions (2017-2027)
2.3.1 Global Biosimilars Market Size (2017-2027)
2.3.2 North America Biosimilars Status and Prospect (2017-2027)
2.3.3 Europe Biosimilars Status and Prospect (2017-2027)
2.3.4 Asia-pacific Biosimilars Status and Prospect (2017-2027)
2.3.5 South America Biosimilars Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Biosimilars Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biosimilars Industry Impact
2.5.1 Biosimilars Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilars Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biosimilars Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biosimilars Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilars Manufacturer Market Share
3.5 Top 10 Biosimilars Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilars Market
3.7 Key Manufacturers Biosimilars Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilars Industry Key Manufacturers
4.1 Roche
4.1.1 Company Details
4.1.2 Roche Biosimilars Product Introduction, Application and Specification
4.1.3 Roche Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Eli Lilly
4.2.1 Company Details
4.2.2 Eli Lilly Biosimilars Product Introduction, Application and Specification
4.2.3 Eli Lilly Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Eli Lilly News
4.3 Sanofi-Aventis
4.3.1 Company Details
4.3.2 Sanofi-Aventis Biosimilars Product Introduction, Application and Specification
4.3.3 Sanofi-Aventis Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sanofi-Aventis News
4.4 Amgen
4.4.1 Company Details
4.4.2 Amgen Biosimilars Product Introduction, Application and Specification
4.4.3 Amgen Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Amgen News
4.5 Novo Nordisk
4.5.1 Company Details
4.5.2 Novo Nordisk Biosimilars Product Introduction, Application and Specification
4.5.3 Novo Nordisk Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Novo Nordisk News
4.6 AbbVie
4.6.1 Company Details
4.6.2 AbbVie Biosimilars Product Introduction, Application and Specification
4.6.3 AbbVie Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AbbVie News
4.7 Merck
4.7.1 Company Details
4.7.2 Merck Biosimilars Product Introduction, Application and Specification
4.7.3 Merck Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Merck News
4.8 Pfizer
4.8.1 Company Details
4.8.2 Pfizer Biosimilars Product Introduction, Application and Specification
4.8.3 Pfizer Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Johnson & Johnson
4.9.1 Company Details
4.9.2 Johnson & Johnson Biosimilars Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 Novartis
4.10.1 Company Details
4.10.2 Novartis Biosimilars Product Introduction, Application and Specification
4.10.3 Novartis Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Gelgen
4.11.1 Company Details
4.11.2 Gelgen Biosimilars Product Introduction, Application and Specification
4.11.3 Gelgen Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Gelgen News
4.12 Ganlee
4.12.1 Company Details
4.12.2 Ganlee Biosimilars Product Introduction, Application and Specification
4.12.3 Ganlee Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Ganlee News
4.13 3sbio
4.13.1 Company Details
4.13.2 3sbio Biosimilars Product Introduction, Application and Specification
4.13.3 3sbio Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 3sbio News
4.14 Innovent
4.14.1 Company Details
4.14.2 Innovent Biosimilars Product Introduction, Application and Specification
4.14.3 Innovent Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Innovent News
4.15 Biotech
4.15.1 Company Details
4.15.2 Biotech Biosimilars Product Introduction, Application and Specification
4.15.3 Biotech Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Biotech News
4.16 Changchun High Tech
4.16.1 Company Details
4.16.2 Changchun High Tech Biosimilars Product Introduction, Application and Specification
4.16.3 Changchun High Tech Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Changchun High Tech News
4.17 Dong Bao
4.17.1 Company Details
4.17.2 Dong Bao Biosimilars Product Introduction, Application and Specification
4.17.3 Dong Bao Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Dong Bao News
4.18 CP Guojian
4.18.1 Company Details
4.18.2 CP Guojian Biosimilars Product Introduction, Application and Specification
4.18.3 CP Guojian Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 CP Guojian News
5 Global Biosimilars Sales Categorized by Regions
5.1 Global Biosimilars Revenue, Sales and Market Share by Regions
5.1.1 Global Biosimilars Sales and Market Share by Regions (2017-2022)
5.1.2 Global Biosimilars Revenue and Market Share by Regions (2017-2022)
5.2 North America Biosimilars Sales and Growth Rate (2017-2022)
5.3 Europe Biosimilars Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Biosimilars Sales and Growth Rate (2017-2022)
5.5 South America Biosimilars Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Biosimilars Sales and Growth Rate (2017-2022)
6 North America Biosimilars Market Size Categorized by Countries
6.1 North America Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 North America Biosimilars Sales (Volume) by Countries (2017-2022)
6.1.2 North America Biosimilars Revenue by Countries (2017-2022)
6.1.3 United States Biosimilars Sales and Growth Rate (2017-2022)
6.1.4 Canada Biosimilars Sales and Growth Rate (2017-2022)
6.1.5 Mexico Biosimilars Sales and Growth Rate (2017-2022)
6.2 North America Biosimilars Revenue (Value) by Manufacturers
6.3 North America Biosimilars Sales and Market Share by Type (2017-2022)
6.4 North America Biosimilars Sales Market Share by Application (2017-2022)
7 Europe Biosimilars Market Size Categorized by Countries
7.1 Europe Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Europe Biosimilars Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Biosimilars Revenue by Countries (2017-2022)
7.1.3 Germany Biosimilars Sales and Growth Rate (2017-2022)
7.1.4 UK Biosimilars Sales and Growth Rate (2017-2022)
7.1.5 France Biosimilars Sales and Growth Rate (2017-2022)
7.1.6 Russia Biosimilars Sales and Growth Rate (2017-2022)
7.1.7 Italy Biosimilars Sales and Growth Rate (2017-2022)
7.1.8 Spain Biosimilars Sales and Growth Rate (2017-2022)
7.2 Europe Biosimilars Revenue (Value) by Manufacturers
7.3 Europe Biosimilars Sales and Market Share by Type (2017-2022)
7.4 Europe Biosimilars Sales Market Share by Application (2017-2022)
8 Asia-Pacific Biosimilars Market Size Categorized by Countries
8.1 Asia-pacific Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Biosimilars Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Biosimilars Revenue by Countries (2017-2022)
8.1.3 China Biosimilars Sales and Growth Rate (2017-2022)
8.1.4 South Korea Biosimilars Sales and Growth Rate (2017-2022)
8.1.5 Japan Biosimilars Sales and Growth Rate (2017-2022)
8.1.6 Australia Biosimilars Sales and Growth Rate (2017-2022)
8.1.7 India Biosimilars Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Biosimilars Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Biosimilars Revenue (Value) by Manufacturers
8.3 Asia-pacific Biosimilars Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Biosimilars Sales Market Share by Application (2017-2022)
9 South America Biosimilars Market Size Categorized by Countries
9.1 South America Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 South America Biosimilars Sales (Volume) by Countries (2017-2022)
9.1.2 South America Biosimilars Revenue by Countries (2017-2022)
9.1.3 Brazil Biosimilars Sales and Growth Rate (2017-2022)
9.2 South America Biosimilars Sales and Market Share by Type (2017-2022)
9.3 South America Biosimilars Sales Market Share by Application (2017-2022)
10 Middle East and Africa Biosimilars Market Size Categorized by Countries
10.1 Middle East and Africa Biosimilars Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Biosimilars Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Biosimilars Revenue by Countries (2017-2022)
10.1.3 GCC Countries Biosimilars Sales and Growth Rate (2017-2022)
10.1.4 Turkey Biosimilars Sales and Growth Rate (2017-2022)
10.1.5 Egypt Biosimilars Sales and Growth Rate (2017-2022)
10.1.6 South America Biosimilars Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Biosimilars Sales and Market Share by Type
10.3 Middle East and Africa Biosimilars Sales Market Share by Application (2017-2022)
11 Global Biosimilars Market Segment by Type
11.1 Global Biosimilars Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Biosimilars Sales and Market Share by Type (2017-2022)
11.1.2 Global Biosimilars Revenue and Market Share by Type (2017-2022)
11.2 Monoclonal Antibodies Sales Growth Rate and Price
11.2.1 Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
11.2.2 Global Monoclonal Antibodies Price (2017-2022)
11.3 Interferon Sales Growth Rate and Price
11.3.1 Global Interferon Sales Growth Rate (2017-2022)
11.3.2 Global Interferon Price (2017-2022)
11.4 Erythropoietin Sales Growth Rate and Price
11.4.1 Global Erythropoietin Sales Growth Rate (2017-2022)
11.4.2 Global Erythropoietin Price (2017-2022)
11.5.1 Global Insulin Sales Growth Rate (2017-2022)
11.5.2 Global Insulin Price (2017-2022)
11.6 Vaccines Sales Growth Rate and Price
11.6.1 Global Vaccines Sales Growth Rate (2017-2022)
11.6.2 Global Vaccines Price (2017-2022)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2017-2022)
11.7.2 Global Other Price (2017-2022)
12 Global Biosimilars Market Segment by Application
12.1 Global Biosimilars Sales Market Share by Application (2017-2022)
12.2 Tumor Sales Growth Rate (2017-2022)
12.3 Diabetes Sales Growth Rate (2017-2022)
12.4 Cardiovascular Sales Growth Rate (2017-2022)
12.5 Hemophilia Sales Growth Rate (2017-2022)
13 Global Biosimilars Market Forecast
13.1 Global Biosimilars Revenue, Sales and Growth Rate (2022-2027)
13.2 Biosimilars Market Forecast by Regions (2022-2027)
13.2.1 North America Biosimilars Market Forecast (2022-2027)
13.2.2 Europe Biosimilars Market Forecast (2022-2027)
13.2.3 Asia-Pacific Biosimilars Market Forecast (2022-2027)
13.2.4 South America Biosimilars Market Forecast (2022-2027)
13.2.5 Middle East & Africa Biosimilars Market Forecast (2022-2027)
13.3 Biosimilars Market Forecast by Type (2022-2027)
13.3.1 Global Biosimilars Sales Forecast by Type (2022-2027)
13.3.2 Global Biosimilars Market Share Forecast by Type (2022-2027)
13.4 Biosimilars Market Forecast by Application (2022-2027)
13.4.1 Global Biosimilars Sales Forecast by Application (2022-2027)
13.4.2 Global Biosimilars Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Biosimilars Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Biosimilars Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilars
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilars Market Size by Type
Figure Global Market Share of Biosimilars by Type in 2021
Figure Monoclonal Antibodies Picture
Figure Interferon Picture
Figure Erythropoietin Picture
Figure Insulin Picture
Figure Vaccines Picture
Figure Other Picture
Table Global Biosimilars Market Size (Volume) by Application
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Table Global Biosimilars Comparison by Regions (M USD) 2017-2027
Figure Global Biosimilars Market Size (Million US$) (2017-2027)
Figure North America Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilars Sales by Manufacturer (2017-2022)
Figure Global Biosimilars Sales Market Share by Manufacturer in 2021
Table Global Biosimilars Revenue by Manufacturer (2017-2022)
Figure Global Biosimilars Revenue Market Share by Manufacturer in 2021
Table Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biosimilars Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biosimilars Market
Table Key Manufacturers Biosimilars Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Biosimilars Product Introduction, Application and Specification of Roche
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Eli Lilly Company Profile
Table Biosimilars Product Introduction, Application and Specification of Eli Lilly
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Sanofi-Aventis Company Profile
Table Biosimilars Product Introduction, Application and Specification of Sanofi-Aventis
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2017-2022
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Amgen Company Profile
Table Biosimilars Product Introduction, Application and Specification of Amgen
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2017-2022
Table Amgen Main Business
Table Amgen Recent Development
Table Novo Nordisk Company Profile
Table Biosimilars Product Introduction, Application and Specification of Novo Nordisk
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2017-2022
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table AbbVie Company Profile
Table Biosimilars Product Introduction, Application and Specification of AbbVie
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Merck Company Profile
Table Biosimilars Product Introduction, Application and Specification of Merck
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Pfizer Company Profile
Table Biosimilars Product Introduction, Application and Specification of Pfizer
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Johnson & Johnson Company Profile
Table Biosimilars Product Introduction, Application and Specification of Johnson & Johnson
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis Company Profile
Table Biosimilars Product Introduction, Application and Specification of Novartis
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Gelgen Company Profile
Table Biosimilars Product Introduction, Application and Specification of Gelgen
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen 2017-2022
Table Gelgen Main Business
Table Gelgen Recent Development
Table Ganlee Company Profile
Table Biosimilars Product Introduction, Application and Specification of Ganlee
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2017-2022
Table Ganlee Main Business
Table Ganlee Recent Development
Table 3sbio Company Profile
Table Biosimilars Product Introduction, Application and Specification of 3sbio
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2017-2022
Table 3sbio Main Business
Table 3sbio Recent Development
Table Innovent Company Profile
Table Biosimilars Product Introduction, Application and Specification of Innovent
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2017-2022
Table Innovent Main Business
Table Innovent Recent Development
Table Biotech Company Profile
Table Biosimilars Product Introduction, Application and Specification of Biotech
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biotech 2017-2022
Table Biotech Main Business
Table Biotech Recent Development
Table Changchun High Tech Company Profile
Table Biosimilars Product Introduction, Application and Specification of Changchun High Tech
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2017-2022
Table Changchun High Tech Main Business
Table Changchun High Tech Recent Development
Table Dong Bao Company Profile
Table Biosimilars Product Introduction, Application and Specification of Dong Bao
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dong Bao 2017-2022
Table Dong Bao Main Business
Table Dong Bao Recent Development
Table CP Guojian Company Profile
Table Biosimilars Product Introduction, Application and Specification of CP Guojian
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian 2017-2022
Table CP Guojian Main Business
Table CP Guojian Recent Development
Figure Global Biosimilars Sales and Growth Rate (2017-2022)
Figure Global Biosimilars Revenue and Growth Rate (2017-2022)
Table Global Biosimilars Sales by Regions (2017-2022)
Figure Global Biosimilars Sales Market Share by Regions in 2021
Table Global Biosimilars Revenue by Regions (2017-2022)
Figure Global Biosimilars Revenue Market Share by Regions in 2021
Figure North America Biosimilars Sales and Growth Rate (2017-2022)
Figure Europe Biosimilars Sales and Growth Rate (2017-2022)
Figure Asia-pacific Biosimilars Sales and Growth Rate (2017-2022)
Figure South America Biosimilars Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Biosimilars Sales and Growth Rate (2017-2022)
Figure North America Biosimilars Revenue and Growth Rate (2017-2022)
Table North America Biosimilars Sales (Volume) by Countries (2017-2022)
Table North America Biosimilars Sales Market Share by Countries (2017-2022)
Figure North America Biosimilars Sales Market Share by Countries in 2021
Table North America Biosimilars Revenue by Countries (2017-2022)
Table North America Biosimilars Revenue Market Share by Countries (2017-2022)
Figure North America Biosimilars Revenue Market Share by Countries in 2021
Figure United States Biosimilars Sales and Growth Rate (2017-2022)
Figure Canada Biosimilars Sales and Growth Rate (2017-2022)
Figure Mexico Biosimilars Sales and Growth Rate (2017-2022)
Table North America Biosimilars Revenue by Manufacturer (2021)
Figure North America Biosimilars Revenue Market Share by Manufacturer in 2021
Table North America Biosimilars Sales by Type (2017-2022)
Table North America Biosimilars Sales Share by Type (2017-2022)
Table North America Biosimilars Sales by Application (2017-2022)
Table North America Biosimilars Sales Share by Application (2017-2022)
Figure Europe Biosimilars Revenue and Growth Rate (2017-2022)
Table Europe Biosimilars Sales (Volume) by Countries (2017-2022)
Table Europe Biosimilars Sales Market Share by Countries (2017-2022)
Figure Europe Biosimilars Sales Market Share by Countries in 2021
Table Europe Biosimilars Revenue by Countries (2017-2022)
Table Europe Biosimilars Revenue Market Share by Countries (2017-2022)
Figure Europe Biosimilars Revenue Market Share by Countries in 2021
Figure Germany Biosimilars Sales and Growth Rate (2017-2022)
Figure UK Biosimilars Sales and Growth Rate (2017-2022)
Figure France Biosimilars Sales and Growth Rate (2017-2022)
Figure Russia Biosimilars Sales and Growth Rate (2017-2022)
Figure Italy Biosimilars Sales and Growth Rate (2017-2022)
Figure Spain Biosimilars Sales and Growth Rate (2017-2022)
Table Europe Biosimilars Revenue by Manufacturer (2021)
Figure Europe Biosimilars Revenue Market Share by Manufacturer in 2021
Table Europe Biosimilars Sales by Type (2017-2022)
Table Europe Biosimilars Sales Share by Type (2017-2022)
Table Europe Biosimilars Sales by Application (2017-2022)
Table Europe Biosimilars Sales Share by Application (2017-2022)
Figure Asia-pacific Biosimilars Revenue and Growth Rate (2017-2022)
Table Asia-pacific Biosimilars Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Biosimilars Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilars Sales Market Share by Countries in 2021
Table Asia-pacific Biosimilars Revenue by Countries (2017-2022)
Table Asia-pacific Biosimilars Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilars Revenue Market Share by Countries in 2021
Figure China Biosimilars Sales and Growth Rate (2017-2022)
Figure South Korea Biosimilars Sales and Growth Rate (2017-2022)
Figure Japan Biosimilars Sales and Growth Rate (2017-2022)
Figure Australia Biosimilars Sales and Growth Rate (2017-2022)
Figure India Biosimilars Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilars Sales and Growth Rate (2017-2022)
Table Asia-pacific Biosimilars Revenue by Manufacturer (2021)
Figure Asia-pacific Biosimilars Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Biosimilars Sales by Type (2017-2022)
Table Asia-pacific Biosimilars Sales Share by Type (2017-2022)
Table Asia-pacific Biosimilars Sales by Application (2017-2022)
Table Asia-pacific Biosimilars Sales Share by Application (2017-2022)
Figure South America Biosimilars Revenue and Growth Rate (2017-2022)
Table South America Biosimilars Sales (Volume) by Countries (2017-2022)
Table South America Biosimilars Sales Market Share by Countries (2017-2022)
Figure South America Biosimilars Sales Market Share by Countries in 2019
Table South America Biosimilars Revenue by Countries (2017-2022)
Table South America Biosimilars Revenue Market Share by Countries (2017-2022)
Figure South America Biosimilars Revenue Market Share by Countries in 2019
Figure Brazil Biosimilars Sales and Growth Rate (2017-2022)
Table South America Biosimilars Sales by Type (2017-2022)
Table South America Biosimilars Sales Share by Type (2017-2022)
Table South America Biosimilars Revenue by Type (2017-2022)
Table South America Biosimilars Revenue Share by Type (2017-2022)
Table South America Biosimilars Sales by Application (2017-2022)
Table South America Biosimilars Sales Share by Application (2017-2022)
Figure Middle East and Africa Biosimilars Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilars Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Biosimilars Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilars Sales Market Share by Countries in 2019
Table Middle East and Africa Biosimilars Revenue by Countries (2017-2022)
Table Middle East and Africa Biosimilars Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilars Revenue Market Share by Countries in 2019
Figure GCC Countries Biosimilars Sales and Growth Rate (2017-2022)
Figure Turkey Biosimilars Sales and Growth Rate (2017-2022)
Figure Egypt Biosimilars Sales and Growth Rate (2017-2022)
Figure South Africa Biosimilars Sales and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilars Sales by Type (2017-2022)
Table Middle East and Africa Biosimilars Sales Share by Type (2017-2022)
Table Middle East and Africa Biosimilars Revenue by Type (2017-2022)
Table Middle East and Africa Biosimilars Revenue Share by Type (2017-2022)
Table Middle East and Africa Biosimilars Sales by Application (2017-2022)
Table Middle East and Africa Biosimilars Sales Share by Application (2017-2022)
Table Global Biosimilars Sales by Type (2017-2022)
Table Global Biosimilars Sales Market Share by Type (2017-2022)
Figure Global Biosimilars Sales Market Share by Type in 2021
Table Global Biosimilars Revenue by Type (2017-2022)
Table Global Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Biosimilars Revenue Market Share by Type in 2019
Figure Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibodies Price (2017-2022)
Figure Global Interferon Sales Growth Rate (2017-2022)
Figure Global Interferon Price (2017-2022)
Figure Global Erythropoietin Sales Growth Rate (2017-2022)
Figure Global Erythropoietin Price (2017-2022)
Figure Global Insulin Sales Growth Rate (2017-2022)
Figure Global Insulin Price (2017-2022)
Figure Global Vaccines Sales Growth Rate (2017-2022)
Figure Global Vaccines Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Other Price (2017-2022)
Table Global Biosimilars Sales by Application (2017-2022)
Table Global Biosimilars Sales Market Share by Application (2017-2022)
Figure Global Biosimilars Sales Market Share by Application in 2021
Figure Global Tumor Sales Growth Rate (2017-2022)
Figure Global Diabetes Sales Growth Rate (2017-2022)
Figure Global Cardiovascular Sales Growth Rate (2017-2022)
Figure Global Hemophilia Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Biosimilars Sales and Growth Rate (2022-2027)
Figure Global Biosimilars Revenue and Growth Rate (2022-2027)
Table Global Biosimilars Sales Forecast by Regions (2017-2022)
Table Global Biosimilars Market Share Forecast by Regions (2017-2022)
Figure North America Sales Biosimilars Market Forecast (2022-2027)
Figure Europe Sales Biosimilars Market Forecast (2022-2027)
Figure Asia-Pacific Sales Biosimilars Market Forecast (2022-2027)
Figure South America Sales Biosimilars Market Forecast (2022-2027)
Figure Middle East & Africa Sales Biosimilars Market Forecast (2022-2027)
Table Global Biosimilars Sales Forecast by Type (2022-2027)
Table Global Biosimilars Market Share Forecast by Type (2022-2027)
Table Global Biosimilars Sales Forecast by Application (2022-2027)
Table Global Biosimilars Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)